Biotech stocks in Hong Kong continue to rally amid hopes of AI-driven development. Bernstein senior analyst Rebecca Liang explains why investors are becoming more optimistic about biotech stocks than last year. She spoke on "Bloomberg: The China Show." (Source: Bloomberg)
Biotech stocks in Hong Kong continue to rally amid hopes of AI-driven development. Bernstein senior analyst Rebecca Liang explains why investors are becoming more optimistic about biotech stocks than last year. She spoke on "Bloomberg: The China Show." (Source: Bloomberg)
<iframe src="https://statesidedaily.com/embed/cluster/8335e48066f6283f3102a37fd32df78f46f37f99" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Bernstein's Liang on China's Biotech Stock Rally"></iframe>